Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
About this item
Full title
Author / Creator
Imran, Mohd , Kumar Arora, Mandeep , Asdaq, Syed Mohammed Basheeruddin , Khan, Shah Alam , Alaqel, Saleh I. , Alshammari, Mohammed Kanan , Alshehri, Mohammed M. , Alshrari, Ahmed Subeh , Mateq Ali, Alreshidi , Al-shammeri, Ahmed Muteb , Alhazmi, Bushra Dhuhayyan , Harshan, Aishah Ali , Alam, Md. Tauquir and Abida, Abida
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
The COVID-19 pandemic needs no introduction at present. Only a few treatments are available for this disease, including remdesivir and favipiravir. Accordingly, the pharmaceutical industry is striving to develop new treatments for COVID-19. Molnupiravir, an orally active RdRp inhibitor, is in a phase 3 clinical trial against COVID-19. The objective...
Alternative Titles
Full title
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_214ea3796c5a4269be217ab2bb78ed1b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_214ea3796c5a4269be217ab2bb78ed1b
Other Identifiers
ISSN
1420-3049
E-ISSN
1420-3049
DOI
10.3390/molecules26195795
